Related by context. All words. (Click for frequent words.) 78 Ozarelix 77 Meets Primary Endpoint 76 FOLOTYN ® 76 Archexin 75 Vicriviroc 75 Phase 2b Clinical Trial 75 Hsp# Inhibitor 75 Pivotal Phase III 74 Phase III Clinical Trial 74 Personalized Immunotherapy 74 Phase IIb Trial 74 Phase III Clinical Trials 74 Completes Patient Enrollment 74 VIVITROL ® 74 Clinical Trial Results 74 Tezampanel 74 Pivotal Phase 73 Tesetaxel 73 TBC# 73 Initiates Enrollment 73 Silodosin 73 Initiate Clinical Trial 73 Patient Enrollment 73 Inhalation Solution 73 Completes Enrollment 73 Bazedoxifene 73 Drug Candidate 73 Combination REOLYSIN R 73 LibiGel ® 73 Phase III Trial 73 Study Evaluating 73 Glufosfamide 73 Transdermal Patch 73 Cetrorelix 73 ospemifene 73 Initiates Clinical 73 Initiates Phase II 72 oral prodrug 72 Serdaxin ® 72 IL# PE#QQR 72 dasatinib Sprycel 72 Safinamide 72 novel histone deacetylase 72 Phase 2b Trial 72 Achieves Primary Endpoint 72 Dasatinib 72 5 HT3 antagonist 72 Denufosol 72 MKC# MT 72 Tasimelteon 72 Pooled Analysis 72 Initiates Clinical Trial 72 MKC# MKC# PP 72 Phase III Pivotal 72 Pivotal Study 72 Romidepsin 72 Ophena TM 72 Phase 2a Clinical Trial 72 diarrhea predominant irritable 72 mGluR5 negative 72 Phase 2b Study 72 Mipomersen 72 receptor tyrosine kinase inhibitor 72 acyclovir Lauriad R 72 delivery polymer matrix 72 Phase IIb Clinical Trial 72 pralatrexate injection folate analogue 72 Phase 2a Trial 71 Initiates Phase III 71 LEVADEX TM 71 Phase III Trials 71 Initiate Phase 71 methylnaltrexone bromide 71 Receives Orphan Drug Designation 71 non nucleoside inhibitor 71 oral renin inhibitor 71 NDA Submission 71 Anturol TM 71 Avanafil 71 Patients Treated With 71 Aflibercept 71 Initiates Clinical Trials 71 Presents Positive 71 forodesine 71 generation purine nucleoside 71 Successfully Completes Phase 71 Submits NDA 71 lucinactant 71 OMNARIS HFA 71 DDP# 71 Adjuvant Treatment 71 dextofisopam 71 refractory chronic lymphocytic 71 JAK Inhibitor 71 Files IND 71 Randomized Phase 71 Traficet EN 71 sodium glucose cotransporter 71 Phase #b/#a clinical 71 Single Dose 71 Indaflex TM 71 Pivotal Clinical Trial 71 Palonosetron 71 Granted Orphan Drug 71 Zoraxel 71 First Patient Dosed 71 FDA APPROVES 71 MEK Inhibitor 71 Initiated Phase 71 OMNARIS Nasal Spray 71 Civacir 71 Presents Preclinical 71 Zorbtive TM 71 Pivotal Trial 71 Investigational Compound 71 Panzem R NCD 71 CCX# 71 Daclizumab 71 Prolongs Survival 71 Testosterone MDTS ® 71 Randomized Double blind 70 PEGylated Fab fragment 70 pan HDAC inhibitor 70 Adjunctive Therapy 70 Panzem R 70 LymphoStat B belimumab 70 SinuNase TM 70 Zemplar Capsules 70 Solazed TM 70 Golimumab 70 Dapagliflozin 70 FUSILEV ® 70 TLK# 70 BYETTA ® 70 evaluating tivozanib 70 tiapamil 70 Diabetic Macular Edema 70 Dalbavancin 70 metaglidasen 70 Begins Dosing 70 ALGRX 70 oral salmon calcitonin 70 PNP inhibitor 70 HDAC Inhibitor 70 PI3K/Akt pathway inhibitor 70 Demonstrates Significant 70 Mg Usa 70 Romiplostim 70 orally inhaled migraine 70 ZEVALIN ® 70 Pirfenidone 70 Immunotherapeutic 70 acetonide FA 70 Bosutinib 70 BAL# [002] 70 mertansine 70 Demonstrates Positive 70 Nilotinib 70 Tofacitinib 70 investigational monoclonal antibody 70 Oral Fingolimod 70 Trial Evaluating 70 induced macular edema 70 Onalta ™ 70 Pafuramidine 70 Epratuzumab 70 registrational trial 70 2 methoxyestradiol 70 Clolar ® 70 AAG geldanamycin analog 70 KRN# 70 immunotherapeutic agent 70 Evoltra ® 70 intranasal formulation 70 LymphoStat B TM 70 Soriatane 70 Lubiprostone 70 R#/MEM # 70 MAGE A3 ASCI 70 selective androgen receptor modulator 70 oncolytic virus therapies 70 Advanced Renal Cell 70 Aliskiren 70 SPRYCEL ® 70 rasagiline tablets 70 Testosterone MDTS R 70 IMiDs ® 70 Tyrosine Kinase Inhibitor 70 oral proteasome inhibitor 70 UPLYSO 70 Phase IIa Clinical Trial 70 Omacetaxine 70 formerly LymphoStat B 70 Quinamed 70 targeted radiotherapeutic 70 Xanafide 70 Ridaforolimus 70 Oral Insulin 70 Soliris eculizumab 69 vidofludimus 69 Investigational Treatment 69 Preclinical Data 69 Ambrisentan 69 PEGylated anti 69 MKC# 69 CYT# potent vascular disrupting 69 Ofatumumab 69 TNF Tumor Necrosis Factor 69 Fabry Disease 69 reslizumab 69 SUPPRELIN R LA 69 R#/MEM 69 candidates Azedra 69 Pertuzumab 69 II Clinical Trial 69 Presents Preclinical Data 69 PRTX 69 Amrubicin 69 Bezielle 69 First Patient Enrolled 69 Milnacipran 69 Benign Prostatic Hyperplasia 69 liposomal formulation 69 evaluating mipomersen 69 Blinatumomab 69 Crofelemer budesonide foam 69 Hepatocellular Carcinoma 69 INT# [002] 69 Mycophenolate Mofetil 69 trastuzumab DM1 T DM1 69 JAK2 Inhibitor 69 Myocet 69 Novolimus 69 RECOTHROM R 69 INCB# [001] 69 Pazopanib 69 BENLYSTA ® 69 Pharmacokinetic Study 69 relapsed MM 69 Microplasmin 69 albiglutide 69 Dose Escalation 69 AFREZZA TM 69 Levoleucovorin 69 Cloretazine 69 Hormone Refractory Prostate Cancer 69 Prodarsan R 69 TO AVOID PREGNANCY WHILE 69 Oracea TM 69 Fidaxomicin 69 sorafenib tablets 69 dasatinib Sprycel ® 69 Talabostat 69 Initiates Phase 69 pan histone deacetylase 69 VISICOL R 69 Decitabine 69 Valopicitabine 69 Sapacitabine 69 YONDELIS 69 Ceflatonin R 69 TELINTRA 69 phase IIb clinical 69 AEG# 69 Pimavanserin 69 MOVIPREP R 69 Gel repository corticotropin injection 69 Deforolimus 69 BENLYSTA TM 69 TRANSDUR ™ 69 docetaxel Taxotere R 69 TRANSDUR ® 69 ALVESCO ® 69 Azedra 69 Glatiramer Acetate 69 Icatibant 69 Pegloticase 69 investigational humanized monoclonal antibody 69 Cannabinor 69 Topline Results 69 Bremelanotide 69 VALSTAR 69 tezampanel 69 Vidaza R 69 ORENCIA ® 69 Novel Oral 69 Diabetic Neuropathy 69 Qutenza TM 69 LEVADEX ™ 69 Protease Inhibitor 69 histone deacetylase HDAC inhibitor 69 octreotide implant 69 IMA# 69 AEGR 69 Metastatic Melanoma 69 molecular imaging radiopharmaceutical 69 Iluvien ® 69 Cleviprex TM clevidipine 69 Sym# 69 PHX# 69 Tesamorelin 69 refractory gout 69 Phase Ib study 69 Announces Poster Presentations 69 Liposomal 69 Clofarabine 69 XYOTAX TM 69 Aurora Kinase 69 Phase IIB 69 Cetuximab Erbitux 69 brand ciclesonide HFA 69 product platforms AZX# 69 herpetic keratitis 69 Toremifene 69 Clinical Trial Evaluating 69 LEP ETU 69 Hedgehog Pathway Inhibitor 69 BiovaxID TM 68 Annamycin 68 Genasense ® oblimersen 68 Cutaneous T 68 Complicated Skin 68 Luteinizing Hormone Releasing Hormone 68 elotuzumab 68 Eltrombopag 68 sodium thiosulfate STS 68 ORENCIA R 68 Nitazoxanide 68 TKB# 68 Double Blind Placebo 68 Receives Approvable Letter 68 Zoraxel TM 68 anticancer compound 68 virus HCV protease inhibitor 68 delivers fluocinolone acetonide FA 68 ALVESCO R 68 Phase IIa trials 68 multicenter Phase III 68 miconazole Lauriad ® 68 Plicera 68 Antitumor Activity 68 Xyfid TM 68 budesonide foam 68 docetaxel Taxotere ® 68 Etravirine 68 CTAP# Capsules 68 castrate resistant prostate cancer 68 Bucindolol 68 Mylan Receives Approval 68 Aryplase 68 PDX pralatrexate 68 Actemra tocilizumab 68 Xcytrin R 68 Oral Mucositis 68 Dyloject TM 68 mGluR5 NAM 68 Vidaza azacitidine 68 alvespimycin 68 R Saizen R 68 PANVAC VF 68 Peginterferon 68 Laquinimod 68 REG1 Anticoagulation System 68 Irinotecan 68 Alocrest 68 Combination Treatment 68 dextromethorphan quinidine 68 Inhalation Aerosol 68 Files Investigational 68 Valsartan 68 Bioral ® 68 serotonin norepinephrine reuptake inhibitor 68 FDA Approvals 68 PREOS R 68 BRIM2 68 Ondansetron Injection USP 68 orally administered inhibitor 68 pharmacokinetic PK study 68 XOPENEX R 68 Spiegelmer ® 68 candidate deforolimus 68 Dose Ranging Study 68 novel VDA molecule 68 NEBIDO R 68 GATTEX TM 68 platinum chemotherapeutic 68 2 inhibitor CYT# 68 Desvenlafaxine Succinate 68 proteasome inhibitor 68 Solazed ™ 68 Gleevec imatinib mesylate 68 Naproxcinod 68 Peginterferon alfa 2b 68 Ustekinumab 68 Humanized Anti 68 Phase 2a Study 68 Voreloxin 68 Pharmacokinetics PK 68 monoclonal antibody conjugated 68 Xeloda ® 68 octreotide acetate 68 developing Bicifadine serotonin 68 omacetaxine mepesuccinate 68 ALN PCS 68 rxRNA 68 RezularTM 68 topically administered 68 Proquin XR 68 Rigel R# 68 TREDAPTIVE 68 Oral Spray 68 Systemic Delivery 68 Phase 1b Clinical Trial 68 dependent kinase inhibitor 68 Present Preclinical Data 68 LHRH antagonists 68 Initiates Phase 2b 68 Fludara ® 68 R lenalidomide 68 Ranolazine 68 RNAi Therapeutic 68 Maribavir 68 Phase 1a clinical 68 Prospective Randomized 68 Presents Positive Preclinical 68 Zelrix 68 Recombinant Human 68 Efficacy Trial 68 Multiple Ascending Dose 68 Albuferon TM 68 Trodusquemine MSI 68 allosteric modulator NAM 68 Methylnaltrexone 68 Factor VIIa 68 Shows Efficacy 68 Temsirolimus 68 Zenvia Phase III 68 Phase Ib Clinical Trial 68 Patient Enrolment 68 Vaprisol 68 Receives Orphan Drug 68 Phase III Pivotal Trial 68 oral taxane 68 autologous cellular immunotherapy 68 CCR9 antagonist 68 IND Application 68 phase III isavuconazole 68 Atripla combines 68 EVIZON TM 68 Intravenous CP 68 Bayer HealthCare Onyx Pharmaceuticals 68 Phase IIIb 68 Telbivudine 68 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 68 telomerase therapeutic 68 JAK inhibitor 68 LHRH antagonist 68 Well Tolerated 68 CCR5 antagonist 68 catheter occlusion 68 Vidofludimus 68 Phase Ib II 68 Randomized Phase II 68 DUROS 68 NUEDEXTA ™ 68 Cerebril TM 68 cannabinor 68 topical non steroidal 67 Zingo TM 67 Brentuximab Vedotin SGN 67 vapreotide acetate 67 nucleoside analog 67 thalidomide Thalomid 67 oral rivaroxaban 67 Tarceva TM 67 oral picoplatin 67 TMC# [002] 67 polymerase inhibitor 67 Testim R 67 5 HT6 receptor 67 Cloretazine ® 67 Central Retinal Vein 67 Enzyme Replacement Therapy 67 IMiDs R 67 Eculizumab 67 candidates Azedra TM 67 Previously Treated 67 Commences Phase 67 ATL/TV# 67 topical gel formulation 67 EOquin 67 Lupus Nephritis 67 successfully commercialize Iluvien 67 ThermoDox R 67 dyskinesia PD LID 67 Raptiva ® 67 Liprotamase 67 INCB# [003] 67 personalized cellular immunotherapy 67 SYCREST 67 Anidulafungin 67 Azedra TM 67 Monoclonal Antibody 67 ACAPODENE 67 lomitapide 67 TAFA# 67 KSP inhibitor 67 imatinib Gleevec ® 67 Kuvan R 67 BCR ABL inhibitor 67 ALN TTR 67 Eszopiclone 67 Interferon Gamma 67 hormone LHRH antagonist 67 interferon gamma 1b 67 topical NSAID 67 RANK Ligand inhibitor 67 Tyrima 67 cancer neuroendocrine tumor 67 clinical trials Archexin 67 HCV Protease Inhibitor 67 ACOMPLIA R 67 NGX# 67 phase IIb trial 67 Pivotal Phase II 67 Hypoactive Sexual Desire Disorder 67 lexidronam injection 67 Phase IIb trials 67 Milestone Payment 67 aripiprazole Abilify 67 GW# [003] 67 Naive Patients 67 orally bioavailable 67 Saxagliptin 67 Interferon Alpha 67 nasal calcitonin product 67 RAPTIVA 67 HCl Tablets 67 hyaluronidase enzyme 67 including eniluracil ADH 67 Spectrum Pharmaceuticals Announces 67 Ocrelizumab 67 erlotinib Tarceva ® 67 efaproxiral 67 Fondaparinux 67 Advanced Melanoma 67 Pulmonary Arterial Hypertension 67 STELARA TM 67 Bepreve TM 67 Kamada AAT 67 Lenocta TM 67 DU #b 67 AVONEX ® 67 AVASTIN 67 Muraglitazar 67 Shows Statistically Significant 67 PrevOnco 67 rALLy clinical trial 67 PGL# 67 ACTEMRA TM 67 Lupus Drug 67 Plenaxis TM 67 Degarelix 67 MoxDuo IR 67 Fast Track Status 67 dopamine partial agonist 67 XL# XL# 67 Expanded Indication 67 AzaSite Plus 67 AZILECT R 67 Anti Tumor Activity 67 EGS# 67 Vitrasert R 67 systemic anaplastic large 67 nucleoside reverse transcriptase inhibitor 67 Febuxostat 67 vaginally administered lidocaine 67 OSMOPREP 67 6R BH4 67 Mg Uk 67 myelodysplastic myeloproliferative diseases 67 Onco TCS 67 cutaneous T 67 Zarnestra 67 teriflunomide 67 Nymox NX 67 pseudobulbar affect PBA 67 Preclinical Models 67 Belimumab 67 HCV protease inhibitors 67 CINQUIL 67 TRIOLEX ™ 67 Aganocide 67 PROVENGE ® 67 TRANSDUR Bupivacaine 67 Prostate AdenoCarcinoma Treatment 67 Rheumatoid Arthritis Drug 67 ONCONASE R 67 KNS # 67 ARRY # 67 Kinase Inhibitor 67 systemic fungal infections 67 Glypromate 67 Anti Tumor 67 PEGINTRON TM 67 Demonstrates Efficacy 67 Oral Calcitonin 67 thetreatment 67 Durezol TM 67 vascular disrupting agents 67 Fulvestrant 67 Pemetrexed 67 Interferon Beta 67 Syncria R 67 Zemiva ™ 67 Acute Attacks 67 Clevudine 67 selective immunoproteasome inhibitor 67 Orally administered 67 PresbyLens ® 67 Adalimumab 67 Lenalidomide 67 FDA Accepts 67 radiation sensitizer 67 Calcitonin 67 By JENNIFER LEARN 67 PEGylated interferon 67 PRN FDA Approves 67 EXPAREL TM 67 Therapeutic Vaccine 67 SPL# Gel vaginal microbicide 67 Augment TM 67 Octreolin 67 ELADUR ™ 67 Testosterone Gel 67 PHASE III 67 Commence Phase 67 GALNS 67 Phase IIIb clinical 67 Phenoptin 67 GVAX ® 67 Entereg R 67 Overactive Bladder 67 LIALDA 67 topically applied SEPA 67 registrational Phase 67 Zenvia ™ 67 R bisoprolol Euthyrox 67 containing granisetron 67 Ovitrelle R Serostim 67 acyclovir Lauriad ® 67 Phase Ib clinical 67 EpiCept NP 1 67 FOR FURTHER INFORMATION ABOUT 67 ibuprofen Injection 67 sublingual tablets 67 sapacitabine CYC# 67 Carfilzomib 67 CD# CEA 67 Alfacell proprietary ribonuclease 67 diabetic neuropathic pain 67 OvaRex ® MAb 67 cetuximab Erbitux 67 cMET 67 GTC recombinant human 67 risedronate sodium tablets 67 HuMax EGFr 67 VA# [002] 67 Fortical R 67 Androxal ® 67 BUPHENYL R 67 cell lymphoma CTCL 67 product candidate Lpathomab 67 corticotropin injection 67 R roscovitine 67 Phase 2a clinical trials 67 nilotinib Tasigna 67 rALLy 67 Tesmilifene 67 Boceprevir 67 BCG refractory carcinoma 67 Apoptone 67 Iluvien TM 67 Follicular Lymphoma 67 INTEGRILIN ® 67 Raptiva R 67 ZEGERID Capsules 67 Genzyme Synvisc 67 BENICAR HCT 67 Novel Antibiotic 67 ularitide 67 Ixempra 67 vinca alkaloid 67 Reports Preclinical Data 67 Plaque Psoriasis 67 Telatinib 67 Iloperidone 67 REPRONEX R menotropins 67 Alemtuzumab 67 Bevacizumab Avastin 67 alvimopan 66 Bicifadine 66 sunitinib malate 66 vinorelbine tartrate 66 CoFactor 66 Cethromycin 66 Renal Cell Carcinoma 66 alfa 2a 66 Therapeutic Competitors Companies 66 Hycamtin ® 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 IMiDs ® compound 66 Squalamine 66 Tamibarotene 66 Sitagliptin 66 Controlled Trial 66 Diabetic Neuropathic Pain 66 PROVENGE sipuleucel T 66 BEMA Granisetron 66 Darusentan 66 SUTENT ® 66 BZL# 66 Eraxis 66 Cancer Vaccines 66 hyperphenylalaninemia HPA due 66 ATL# [001] 66 Ostabolin C TM 66 Zoraxel ™ 66 Ganciclovir 66 highly selective inhibitor 66 Intravenous Formulation 66 cromolyn sodium 66 constipation OIC 66 Besivance 66 Marqibo TM 66 IV APAP 66 biologic DMARD 66 INS# [001] 66 Tasigna nilotinib 66 thiazolidinedione TZD 66 ILUVIEN ® 66 tubulin inhibitor 66 GARDASIL ® 66 Soriatane R 66 investigational pan BCR 66 HCV protease inhibitor 66 azilsartan medoxomil 66 POSIDUR TM 66 volociximab 66 tanespimycin 66 Selective Electrochemical Tumor Ablation 66 fosbretabulin 66 Chronic Lymphocytic Leukemia 66 overactive bladder syndrome 66 Pralatrexate 66 PSN# [002] 66 oral nucleoside analogue 66 Long Term Efficacy 66 Nexavar ® 66 Intravitreal 66 XL# anticancer compounds 66 Betaferon R 66 evaluating satraplatin 66 5 fluorouracil leucovorin 66 candidate XP# 66 Cellegesic 66 VYVANSE TM lisdexamfetamine 66 baminercept 66 Xolegel 66 Warfarin Coumadin 66 Desvenlafaxine 66 Tekturna HCT 66 ABILIFY ® 66 MEK inhibitor 66 Frova ® 66 cathepsin K inhibitor 66 ADP receptor antagonist 66 novel oral anticoagulant 66 Saforis 66 Vandetanib 66 Triolex 66 Trastuzumab DM1 66 Combination Therapy 66 AVAPRO 66 Bortezomib 66 Navelbine ® 66 DAVANAT 66 SUCCEED trial 66 phase IIb III 66 ARIXTRA R 66 phase IIa 66 DXL# 66 Gemzar ® 66 oral FTY# 66 ALN HPN 66 Phase #/#a trial 66 Randomized Double Blind 66 Capesaris 66 Rebif ® 66 Preclinical Study 66 Inhalation Powder 66 SCH # 66 Severe Sepsis 66 Etanercept 66 Prestara TM 66 BrachySil TM 66 LE SN# 66 Angiotensin Converting Enzyme 66 Disease IBD 66 rusalatide acetate 66 Vimpat R 66 Improves Outcomes 66 RELISTOR ® 66 Zybrestat 66 Vaccine Adjuvant 66 PDE4 inhibitor 66 Intravenous Human 66 urethral bulking agent 66 selective kinase inhibitor 66 erlotinib Tarceva R 66 APEX PD 66 Luveniq 66 PEG SN# 66 assessing T DM1 66 HuMax TAC 66 CCR5 mAb 66 MyVax R 66 Preclinical Efficacy 66 AZILECT ® 66 trospium 66 Ferumoxytol 66 TRANSFORMS 66 ProLindac TM 66 SinuNase ™ 66 hypoxia activated prodrug 66 Gamunex C 66 Kepivance 66 eosinophilic asthma 66 refractory cutaneous T 66 Xyrem ® 66 Gonal f R 66 oral ghrelin agonist 66 Onalta 66 CEQ# 66 LUNESTA TM 66 selective modulator 66 Submits Biologics License Application 66 Metastatic Prostate Cancer 66 sapropterin dihydrochloride 66 Lysteda 66 ABLYNX 66 Chemophase 66 Sanofi Pasteur Fluzone 66 Pivotal Trials 66 Initiate Phase III 66 Epeius Biotechnologies Corporation 66 Relapsed Refractory 66 forodesine hydrochloride 66 benign prostatic hypertrophy BPH 66 Emollient Foam 66 Novel Compound 66 recurrent metastatic ovarian cancer 66 Zenvia TM 66 Montelukast 66 Aurexis 66 immunotherapeutic vaccine 66 GABITRIL 66 Eniluracil 66 leading oral taxane 66 CRMD# 66 Demonstrates Potent 66 SAR# [002] 66 VALSTAR TM 66 OncoVEX GM CSF 66 R metformin Concor 66 Nasdaq OPTR 66 Custirsen 66 Polymerase Inhibitor 66 Receives Positive Opinion 66 treat chronic sinusitis 66 pregabalin Lyrica 66 Corlux 66 CYP#A# CYP#D# 66 Rotavirus Vaccine 66 Guanilib 66 Fibrin Patch 66 Hemispherx flagship products 66 Vion Pharmaceuticals 66 Hypercholesterolemia 66 sorafenib Nexavar 66 pertuzumab 66 XYZAL R 66 ocular formulation 66 Tracleer R 66 Gastrointestinal Stromal Tumors 66 Ketorolac 66 transdermal spray 66 Orapred ODT 66 Cholesterol Lowering Drug 66 candidate Zenvia 66 systemic juvenile idiopathic 66 Dupuytren Contracture 66 Luramist TM 66 eltrombopag 66 ELADUR TM 66 evaluating bafetinib 66 ferumoxytol Injection 66 platform HDL Mimetic 66 EDEMA3 66 Zeldox 66 non metastatic osteosarcoma 66 Sanctura XR 66 phase IIb study 66 HuMax CD4 66 Interferon beta 1a 66 CIMZIA TM 66 LEUKINE 66 Calcium Acetate 66 Benazepril 66 investigational antiplatelet agent 66 investigational pharmacologically unique 66 Tipranavir 66 overactive bladder VANTAS R 66 Dual Opioid 66 CIMZIA ™ 66 nalbuphine ER 66 Confirmatory Phase 66 NAVISTAR R 66 metastatic malignant 66 L BLP# 66 epothilone 66 HGS ETR2 66 Completes Dosing 66 markets HP Acthar 66 CD3 monoclonal antibody 66 PROSTASCINT R 66 Drug Eluting Stent System 66 opioid induced bowel dysfunction 66 Secondary Hyperparathyroidism 66 Vernakalant 66 Simulect 66 nucleotide analog 66 candidate CRLX# 66 Late Breaker 66 Troxatyl 66 luteinizing hormone releasing 66 Thiarabine 66 Pramlintide 66 iobenguane 66 Varespladib 66 ofatumumab HuMax CD# 66 Diabetic Macular Edema DME 66 Transcept Pharmaceuticals 66 galiximab 66 oral dual endothelin 66 Perifosine 66 CRD5 66 PROMUS Element Stent 66 ixabepilone 66 Acute Ischemic Stroke 66 ganetespib 66 antibody MAb 66 sitaxsentan 66 chronic idiopathic thrombocytopenic purpura 66 INC# 66 Moxifloxacin 66 BCR ABL inhibitors 66 Tanespimycin 66 YONDELIS R 66 Benign Prostatic Hyperplasia BPH 66 EOquin TM 66 PRT# 66 mGluR2 positive 66 OTCBB CVBT 66 Aloxi ® 66 Brimonidine 66 Lung Cancer Trial 66 IND Filing 66 oxybutynin gel 66 topiramate Topamax 66 See CLINICAL PHARMACOLOGY 66 Exelixis compounds 66 cell carcinoma RCC 66 dihydrochloride Tablets 66 Evamist TM 66 Treated Patients 66 pioglitazone HCl 66 liver resection surgeries 66 dexamethasone Decadron 66 PRISTIQ 66 Fluconazole 66 Paraplatin ® 66 gefitinib Iressa 66 Myelodysplastic Syndromes 66 NUVIGIL ® 66 Hepatocellular Carcinoma HCC 66 essential thrombocythemia ET 66 Onconase 66 unique alkylating agent